Influence of GSTM1 genotype on comet assay and chromosome aberrations after induction by bleomycin in cultured human lymphocytes

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 469, Issue 2, 2000, Pages 199-205

  Kocabas, Neslihan Aygün ^a   Karahalil, Bensu ^a   Karakaya, Ali Esat ^a   Sardas, Semra ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Alkaline comet assay; BLM induction; Chromosome aberration; GSTM1 genotype

Indexed keywords

BLEOMYCIN;

ADULT; ARTICLE; CARCINOGENESIS; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; MALE; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; BASE SEQUENCE; BLEOMYCIN; CELLS, CULTURED; CHROMOSOME ABERRATIONS; COMET ASSAY; DNA PRIMERS; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LYMPHOCYTES; MALE; MOLECULAR SEQUENCE DATA; NEOPLASMS; RISK FACTORS;

EID: 0034692613     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(00)00076-0     Document Type: Article

References (23)

1. Mannervik B., Awasthi Y.C., Board P.G., Hayes J.D., Di Illio C., Ketterer B., Listowsky I., Morgenster R., Muratmatsu M., Pearson W.R., Pickett C.B., Sato K., Winderster M., Wolf C.F. Nomenclature for human glutathione-S-transferase. Biochem. 282:1992;305-306.
2. Black S.M., Wolf C.R. The role of glutathione-dependent enzymes in drug resistance. Pharmacol. Ther. 51:1991;139-154.
3. Board P.G. Biochemical genetics of glutathione-S-transferases in man. Am. J. Hum. Genet. 33:1981;36-43.
4. Seidegard J., Pero R.W., Markowitz M., Roush G., Miller W.R., Beattie E.J. Isozyme(s) of glutathione transferase (class mu) as a marker for the susceptibility to lung cancer: a follow up study. Carcinogenesis. 11:1990;33-36.
5. Seidegard J., Pero R.W., Miller D.G., Beattie E.J. A glutathione transferase in human leucocytes as a marker for the susceptibility to lung cancer. Carcinogenesis. 7:1986;751-753.
6. Harada S., Abai M., Tanaka N., Agarwal D., Goedde H.W. Liver glutathione S-transferase polymorphism in Japanese and its pharmacogenetic importance. Hum. Genet. 75:1987;322.
7. Hsu T.C., Johnston D.A., Cherry L.M. Sensitivity to genotoxic effects of BLM in humans: possible relationship to environmental carcinogenesis. Int. J. Cancer. 43:1989;403-409.
8. Spitz M.R., Fueger J.J., Beddingrield N.A. Chromosome sensitivity to BLM-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res. 49:1989;4626-4628.
9. Chatterjee A., Jacob-Raman M. A comparison of aberration distribution and cell cycle progression in cells treated with bleomycin with those exposed to X-rays. Mutat. Res. 202:1988;51-57.
10. Povirk L.F., Austin N.J.F. Genotoxicity of bleomycin. Mutat. Res. 257:1991;127-143.
11. Lown W., Sim S.K. The mechanism of bleomycin induced cleavage of DNA. Biochem. Biophys. Res. Commun. 77:1977;1150-1157.
12. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantification of low levels of DNA damage in individual cells. Exp. Cell Res. 175:1988;184-191.
13. R.R. Tice, N.P. Andrews, N.P. Singh, The single cell gel assay: A sensitive technique for evaluating intercellular differences in DNA damage and repair, in: Sutherland, B.M. Woodhead, A.D. (Eds.), DNA Damage and Repair in Human Tissues, Plenum Press, New York, 1990, pp. 291-301.
14. J. Sambrook, E.F. Fritsch, R. Maniatis, Molecular Cloning: A Laboratory Manual, 2nd Edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
15. Zhong S., Wyllie A.H., Barnes D., Wolf C.R., Spurr N.K. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon-cancer. Carcinogenesis. 14:1993;1821-1824.
16. Comstock K.E., Sanderson B.J.S., Claflin G., Henner W.D. GSTM1 gene deletion determined by polymerase chain reaction. Nucleic Acids Res. 18:1990;3670.
17. Povirk L.F. DNA damage and mutagenesis by radiomimetic DNA-cleaving agents: bleomycin, neocarzinostatin and other enediynes. Mutat. Res. 355:1996;71-89.
18. 450 polymorphism as risk factors for squamous cell carcinoma of the larynx. Am. J. Surg. 172:1996;671-673.
19. Nakachi K., Jmai K., Hayashi S.I., Kawajiri K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res. 53:1993;2994-2999.
20. Kihara M., Noda K. Lung cancer of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure. Carcinogenesis. 15:1994;415-418.
21. Hirvonen A., Nylund L., Kociba P., Husgafvel-Pursiainen K., Vainio H. Modulation of urinary mutagenecity by genetically determined carcinogen metabolism in smokers. Carcnogenesis. 15:1994;813-815.
22. Nyberg F., Hou S.M., Hemminki K., Lambert B., Pershagen G. Glutathione S transferase mu1 and N-acetyltransferase2 genetic polymorphism and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls. Cancer Epidemiol. Biomarkers Prov. 10:1998;875-883.
23. Betti C., Davini T., Giannessi L., Loprieno N., Barale R. Comparative studies by comet test and SCE analysis in human lymphocytes from 200 healthy subjects. Mutat. Res. 343:1995;201-207.